|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
Sources: | ||||||||||||||||
Jillian Ball, “Diet Pills with Amphetamines,” www.livestrong.com, Oct. 21, 2013
Belviq, “Belviq Prescribing Information,” www.belviq.com, Aug. 2012 George A. Bray, “History of Obesity,” Obesity: Science to Practice, Eds. Gareth Williams and Gema Frühbeck, 2009 George A. Bray, “Some Historical Aspects of Drug Treatment for Obesity,” Pharmacotherapy of Obesity, Ed. John P.H. Wilding, 2008 P.A. Cohen, A. Goday, and J.P. Swann, “The Return of Rainbow Diet Pills,” American Journal of Public Health, Sep. 2012 FDA, “Akyuz, Sinan 11/16/09 – Warning Letter,” www.fda.gov, Nov. 16, 2009 FDA, “Calories Count: Report of the Working Group on Obesity,” www.fda.gov, Mar. 12, 2004 FDA, “Early Communication about an Ongoing Safety Review Orlistat (Marketed as Alli and Xenical),” www.fda.gov, Aug. 24, 2009 FDA, “FDA Announces Withdrawal FenFluramine and Dexfenfluramine (Fen-Phen),” www.fda.gov, Sep. 17, 1997 FDA, “FDA Approved Obesity Drugs,” www.fda.gov (accessed July 21, 2011) FDA, “FDA Approves Belviq to Treat Some Overweight or Obese Adults,” www.fda.gov, June 27, 2012 FDA, “FDA Drug Safety Communication: FDA Recommends against the Continued Use of Meridia (sibutramine),” www.fda.gov, Oct. 8, 2010 FDA, “Medication Guide: Qsymia,” www.fda.gov, 2013 FDA, “Questions and Answers about FDA’s Initiative against Contaminated Weight Loss Products,” www.fda.gov, Sep. 3, 2013 FDA, “Warning on Hydroxycut Products,” www.fda.gov, May 1, 2009 Tse-Ling Fong, MD, et al., “Hepatotoxicity Due to Hydroxycut: A Case Series,” American Journal of Gastroenterology, July 2010 J. Grundlingh, P.I. Dargan, M. El-Zanfaly, and D.M. Wood, “2,4-dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death,” Journal of Medical Toxicity, Sep. 2011 Alok, K. Gupta and Frank L. Greenway, “Safety of Obesity Drugs,” Obesity: Epidemiology, Pathophysiology and Prevention, Eds. Debasis Bagchi and Harry G. Preuss, 2007 Debra Henn and Deborah DeEugenio, Diet Pills, 2009 P. Hollander, A.K. Gupta, R. Plodkowski, F. Greenway, H. Bays, C. Burns, P. Klassen, and K. Fujioka, “Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients with Type 2 Diabetes,” Diabetes Care, Dec. 2013 Hydroxycut, “Homepage,” www.hydroxycut.com (accessed July 21, 2011) Jason Kane, “New Weight Loss Pill Gets Second Look from FDA, Stirring Old Fears,” www.pbs.org, Feb. 22, 2012 Medline Plus, “Diethylpropion,” www.nlm.nih.gov, Nov. 20, 2012 National Center for Biotechnology Information (NCIB), “Diethylpropion,” PubMed Health database, www.ncbi.nlm.nih.gov, Sep. 1, 2008 National Center for Biotechnology Information (NCIB), “Phentermine,” PubMed Health database, www.ncbi.nlm.nih.gov, Jan. 1, 2011 Amy Norton, “Hydroxycut Linked to Other Cases of Liver Damage,” www.reuters.com, Feb. 12, 2010 Orexigen, “FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity,” www.orexigen.com, Feb. 1, 2011 Phentermine.com, “Side Effects,” www.phentermine.com (accessed Apr. 22, 2014) Andrew Pollack, “Abbott Labs Withdraws Meridia from the Market,” www.nytimes.com, Oct. 8, 2010 Andrew Pollack, “F.D.A. Rejects Qnexa, a Third Weight-Loss Drug,” www.nytimes.com, Oct. 28, 2010 Andrew Pollack, “No F.D.A. Approval for New Diet Pill,” www.nytimes.com, Oct. 23, 2010 Robert Pool, Fat: Fighting the Obesity Epidemic, 2001 Steven Reinberg, “Possible Reason for Rimonabant’s Side Effects Discovered,” www.consumer.healthday.com, Mar. 24, 2008 Phillip Strange, “DNP: The Return of a Deadly Weight-Loss Drug,” www.theguardian.com, Feb. 6, 2014 Mark Subsinsky, “The Butterfly Effect: The Basics of the Thyroid, Part 2,” www.bodybuilding.com, May 4, 2005 University of Maryland Center for Substance Abuse Research, “Amphetamines,” www.cesar.umd.edu, Oct. 29, 2013 WebMD, “Drugs & Medications – Meridia Oral,” www.webmd.com (accessed Apr. 23, 2014) WebMD, “Drugs & Medications – Phentermine,” www.webmd.com (accessed Apr. 23, 2014) David S. Weigle, “Pharmacological Therapy of Obesity: Past, Present, and Future,” Journal of Clinical Endocrinology & Metabolism, June 2003 Xenical, “Important Safety Information,” www.xenical.com, 2012 Alison Young, “Nine Diet Supplements Contain Amphetamine-Like Compound,” www.usatoday.com, Nov. 18, 2013 |
More to Explore |
---|
Should Chocolate Milk Be Available in Schools? |
Calories Burned During Activities |
International Meat Consumption |